Dialogues in Dermatology: JAK Inhibitors

Peter Lio, MD, FAAD interviewed by Jacquelyn Dosal, MD, FAAD commentary by Angelia L. Stepien, DO with Todd Schlesinger, MD, FAAD (ed.)

JAK inhibitors have been studied to treat a wide range of dermatologic conditions. Listen as Peter Lio, MD, FAAD and Jacquelyn Dosal, MD, FAAD discuss newly approved medications and how to work as a multidisciplinary team when managing these patients.

View episode transcript